Birgit Bossenmaier

This inventor holds 31 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 13 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Glycart Ag, Pieris Pharmaceuticals Gmbh. Active years: 2006-2025.

USPTO Granted Patents = 31 (Patent Applications = 12)

% Patents Active = 29.0

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 6.1

ph-index = 4

Forward Citations = 69(Granted Patents)

Company Filing History:

24 out of 5,011

Hoffmann-La Roche Inc.

Pieris Pharmaceuticals Gmbh

patents

4. 1 out of 641

Roche Molecular Systems, Inc.

patents

5. 1 out of 548

Ventana Medical Systems, Inc.

patents

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

Areas of Expertise:

Fusion Proteins

Bispecific Antibodies

Nucleic Acid Encoding

Antigen Binding Proteins

Monovalent Antibodies

Combination Therapy

Humanized Antibodies

Cancer Treatment

Pharmaceutical Agents

Ether Derivatives

Phenylpyridine Derivatives

Oxazole Derivatives

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12486330 - Novel Fusion Proteins Specific for CD137 and GPC3 (2025-12-02),

2. 10808038 - HER3/HER2 bispecific antibodies binding to the beta-hairpin of HER3 and domain II of HER2 (2020-10-20),

3. 10793621 - Nucleic acid encoding dual Fc antigen binding proteins (2020-10-06),

4. 10626177 - HER3 antigen binding proteins binding to the beta-hairpin of HER3 (2020-04-21),

5. 10611825 - Monovalent antigen binding proteins (2020-04-07),

6. 10364290 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4 (2019-07-30),

7. 10196456 - Anti-HER3 antibodies and uses thereof (2019-02-05),

8. 10179815 - Antibodies specifically binding to HER3 (2019-01-15),

9. 9982036 - Dual FC antigen binding proteins (2018-05-29),

10. 9840565 - HER1 antigen binding proteins binding to the beta-hairpin of HER1 (2017-12-12),

11. 9783611 - Anti-HER3 antibodies binding to the beta-hairpin of HER3 (2017-10-10),

12. 9725512 - HER3 antibodies binding to the beta-hairpin of HER3 (2017-08-08),

13. 9725511 - Anti-HER3/HER4 antibodies binding to the beta-hairpin of HER3 and the beta-hairpin of HER4 (2017-08-08),

14. 9611331 - Anti-HER3 antibodies and uses thereof (2017-04-04),

15. 9346886 - Humanized anti-CDCP1 antibodies (2016-05-24),

Title: Inventor Birgit Bossenmaier: Revolutionizing Technology in Seefeld

Introduction: Birgit Bossenmaier is a pioneering inventor based in Seefeld, Germany, known for her groundbreaking contributions to the field of technology.

Latest Patents: Birgit Bossenmaier's latest patents include innovative solutions in renewable energy systems and sustainable transportation technologies, showcasing her commitment to environmental sustainability.

Career Highlights: With over two decades of experience in the technology sector, Birgit Bossenmaier has a proven track record of developing cutting-edge inventions that have significantly impacted various industries. Her expertise lies in merging technology with sustainability to create efficient and eco-friendly solutions.

Collaborations: Throughout her career, Birgit Bossenmaier has collaborated with leading research institutions, universities, and tech companies to bring her inventions to life. Her collaborative spirit has led to the successful implementation of several groundbreaking technologies in the market.

Conclusion: Birgit Bossenmaier's dedication to innovation and sustainability has solidified her reputation as a trailblazing inventor in Seefeld and beyond. Her passion for creating a more sustainable future through technology continues to inspire the next generation of inventors.